Jupiter Research Capital (Asia) Ltd’s MapLight Therapeutics MPLT Stock Holding History
Bought
Maintained
Sold
Other funds holding MPLT
Jupiter Research Capital (Asia) Ltd's MPLT Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of MapLight Therapeutics (MPLT) in Q3 2026, closing a stake of 8,018 shares — an estimated $287K sold.
Jupiter Research Capital (Asia) Ltd first reported a position in MPLT in Q2 2026 and held it in 1 quarter. The position peaked at $287K in Q2 2026. 85 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining MapLight Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 8,018 MapLight Therapeutics shares in Q3 2026, an estimated $287K.
- Jupiter Research Capital (Asia) Ltd first reported a position in MapLight Therapeutics in Q2 2026 and held it in 1 quarter.
- Jupiter Research Capital (Asia) Ltd's MapLight Therapeutics position peaked at $287K in Q2 2026.
- 85 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.